UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2018

 

Commission File Number 001-37381

 

MEDIGUS   LTD.

(Translation of registrant’s name into English)

 

Omer Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   __

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   __

 

 

 

 

 

 

EXPLANATORY NOTE

 

In connection with Medigus Ltd.'s, or the Company, annual general meeting to be convened on September 20, 2018, or the Meeting, the Company hereby furnishes herewith as exhibit 99.1 a letter to the shareholders by the board of directors relating to the proposals to be voted upon at the Meeting.

 

  - 1 -  

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  MEDIGUS LTD.
     
Date: September 7, 2018 By: /s/ Oded Yatzkan
    Oded Yatzkan
    Chief Financial Officer

 

  - 2 -  

 

 

EXHIBIT INDEX

 

Exhibit   Description
     
99.1     Shareholders letter by the board of directors of Medigus Ltd., dated September 7, 2018.

 

  - 3 -  

 

Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Medigus Charts.
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Medigus Charts.